Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-24-006957
Filing Date
2024-07-31
Accepted
2024-07-31 17:18:12
Documents
20

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1863328
2 filename2.htm EX-4.2 217925
3 GRAPHIC g769642g01p52.jpg GRAPHIC 30931
4 GRAPHIC g769642g05f43.jpg GRAPHIC 601719
5 GRAPHIC g769642g07s01.jpg GRAPHIC 53931
6 GRAPHIC g769642g30x67.jpg GRAPHIC 36350
7 GRAPHIC g769642g31l38.jpg GRAPHIC 50551
8 GRAPHIC g769642g55a01.jpg GRAPHIC 52982
9 GRAPHIC g769642g55f74.jpg GRAPHIC 58099
10 GRAPHIC g769642g62f25.jpg GRAPHIC 64074
11 GRAPHIC g769642g66t55.jpg GRAPHIC 32846
12 GRAPHIC g769642g72h13.jpg GRAPHIC 35890
13 GRAPHIC g769642g72u41.jpg GRAPHIC 29072
14 GRAPHIC g769642g76l04.jpg GRAPHIC 54832
15 GRAPHIC g769642g77q77.jpg GRAPHIC 33838
16 GRAPHIC g769642g81q05.jpg GRAPHIC 40409
17 GRAPHIC g769642g94f07.jpg GRAPHIC 123901
18 GRAPHIC g769642g96l94.jpg GRAPHIC 67135
19 GRAPHIC g769642g98g45.jpg GRAPHIC 43304
20 GRAPHIC g769642g98o36.jpg GRAPHIC 31282
  Complete submission text file 0000950123-24-006957.txt   4056353
Mailing Address 171 OYSTER POINT BOULEVARD, SUITE 300 SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BOULEVARD, SUITE 300 SAN FRANCISCO CA 94080 6508505070
Maze Therapeutics, Inc. (Filer) CIK: 0001842295 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-07295 | Film No.: 241163035
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)